Long-term prognostic value for patients with chronic heart failure of estimated glomerular filtration rate calculated with the new CKD-EPI equations containing cystatin C

Clinical Chemistry

Volumn 60, Issue 3, 2014, Pages 481-489

  Zamora, Elisabet ^a,b   Lupón, Josep ^a,b   De Antonio, Marta ^a,b   Vila, Joan ^c,d   Peñafiel, Judith ^c,d   Galán, Amparo ^a   Urrutia, Agustín ^a,b   Domingo, Mar ^a   Bayes Genis, Antoni ^b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; RECEPTOR BLOCKING AGENT; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MIDDLE AGED; MORTALITY; OUTPATIENT; PROGNOSIS;

AGED; BIOLOGICAL MARKERS; CHRONIC DISEASE; CREATININE; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MATHEMATICAL CONCEPTS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; ROC CURVE;

EID: 84895805851     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.212951     Document Type: Article

References (20)

1. Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Philips CO, DiCapua P, Krumholz HM. Renal impairment and outcomes in heart failure. Systematic review and meta-analysis. J Am Coll Cardiol 2006;47:1987-96.
2. de Silva R, Nikitin NP, Witte KK, Rigby AS, Goode K, Bhandari S, et al. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur Heart J 2006;27:569-81.
3. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure. Prognostic and therapeutic implications from a prospective cohort study. Circulation 2004;109:1004-9. (Pubitemid 38282853)
4. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
5. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000;11(Suppl):155A.
6. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12.
7. Zamora E, Lupón J, Vila J, Urrutia A, de Antonio M, Sanz H, et al. Estimated Glomerular Filtration Rate and prognosis in heart failure. Value of the Modification of Diet in Renal Disease Study-4, Chronic Kidney Disease Epidemiology Collaboration, and Cockroft-Gault formulas. J Am Coll Cardiol 2012;59:1709-15.
8. Lassus J, Harjola V, Sund R, Siirilä-Waris K, Melin J, Peuhkurinen K, et al. for the FINN-AKA Study Group. Prognostic value of Cystatin-C in acute heart failure in relation to other markers of renal function and NT-proBNP. Eur Heart J 2007;28:1841-7. (Pubitemid 47236639)
9. Naruse H, Ishii J, Kawai T, Hattori K, Ishikawa M, Okumura M, et al. Cystatin-C in acute heart failure without advanced renal impairment. Am J Med 2009;122:566-73.
10. Gao C, Zhong L, Gao Y, Li X, Zhang M, Wei S. Cystatin C levels are associated with the prognosis of systolic heart failure patients. Arch Cardiovasc Dis 2011;104:565-71.
11. Peralta CA, Katz R, Sarnak MJ, Ix J, Fried LF, De Boer I, et al. Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol 2011;22:147-55.
12. Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 2011;305:1545-52.
13. Levey AS, Coresh J, Greene T, Stevens LA, Zhang Y, Hendriksen S, et al, for the Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-54. (Pubitemid 46768608)
14. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012;367:20-9.
15. Zamora E, Lupón J, de Antonio M, Vila J, Galán A, Gastelurrutia P, et al. Limited value of cystatin-C over estimated glomerular filtration rate for heart failure risk stratification. PloS One 2012;7:e51234.
16. Belville M, Crouse SP, Clark D, Gorman RT. Correlation factors for correlating Jaffe creatinine (CREA) methods to the IDMS creatinine reference procedure. Technical bulletin D-01674, version 1.0. Deerfield (IL): Siemens Healthcare Diagnostics; 2011.
17. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10. (Pubitemid 16134762)
18. Pencina MJ, D'Agostina RB, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Statist Med 2011;30:11-21.
19. Shlipack MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 2013;369:932-43.
20. Research Funding: Cystatin assays were provided by Radim Ibérica. M. de Antonio, competitive research grant from the Catalan Society of Cardiology; A. Bayes-Genis, research network Redes Temáticas de Investigación Cooperativa en Salud (RETICS) Red Cardiovascular (RD12/0042/0047).